Opana ER® Class Action Settlement
Updated: January 8, 2023
Settlement Status: Closed
Claim Form Deadline: January 5, 2023
Proof required: No
Method of payment: Mailed Check
Opana ER Class Action Lawsuit
A $15 Million class action lawsuit has been settled with Endo Pharmaceuticals, the maker of Opana ER, an opioid (painkiller) drug. If you took Opana ER, you may be eligible for a class action payment. The class action covers people who have been
overcharged for medications due to Impax and Endo's monopolistic antitrust practices. If you
qualify, you can get back what has been taken from your pocketbook.
What's This Settlement About?
The $15 Million class action settlement fund was agreed upon with Impax Laboratories, a generic drug manufacturer, as a result of working with the larger Endo Pharmaceuticals to fix prices of Opana ER, the opiate sold and marketed by Endo. The class action lawsuit claimed that Endo Pharmaceuticals and Impax Laboratories colluded and promised each other heightened profits in an effort to fix prices. They did so, allegedly, by entering an agreement for Impax not to market an authorized, generic version of Opana ER, which was worth millions of dollars net on the market.
The Opana Class Action Lawsuit alleges that the payment or payments from Endo Pharmaceuticals to Impax Laboratories was part of an agreement which delayed the entry of generic Opana ER, allowing Endo to charge rampantly overcharged prices for its branded product, which third party payors (such as insurers) were forced to pay, as well as ordinary consumers).
The lawsuit also alleges that Endo and Impax violated state antitrust
laws by conspiring to delay generic competition and thus to raise drug prices artificially. According to the class action
complaint, Endo and Impax entered into this agreement illegally and profited off of patients, consumers, and third party payors such as insurers, which inevitably pass down these costs to the ordinary American insured. It is another blatant example of corruption in the health care and pharmaceutical industries in the United States.
How Do I Qualify?
If you were prescribed Opana ER, you may have overpaid for it due to anticompetitive measures taken by Endo Pharmaceuticals and generic drugmaker Impax. You may be eligible for a class action lawsuit payout. Compensation for your overpayment is contingent on your filing a valid and timely claim. The
amount of compensation will depend on the number of people who join
this class action lawsuit as legitimate class action members, and how much each class action member was overcharged.
According to the class action lawsuit, scores of people have overpaid and thus have been hurt, or damaged, by Opana ER price fixing, and it is important
that they know about this settlement and have an opportunity to recover some of the money for overpriced Opana ER medication.
The purchase of Opana ER must have been made some time between April 2011 and September 2018 in the following states:
• Washington DC,
• New Hampshire,
• New Mexico,
• New York,
• North Carolina,
• North Dakota,
• South Dakota,
• West Virginia,
How Do I File a Claim?
You may receive
compensation if you are eligible for settlement based on the above qualifying requirements. Submissions must have been
received by January 5, 2023 at the very latest.
If and when the court approves the Opana ER Class Action Settlement, class action notices will be sent to all eligible
claimants by mail or email. Eligible claimants must submit supporting
documents with their claims if they want to receive payment under the
settlement. The court will hold a final approval hearing on whether to approve the
settlement in November 2022. If approved, notice will be sent to all
What if I Don't Qualify or Missed This Class Action?
Look for other Class Action Settlements you do qualify for and get notified of new ones as they come by subscribing to the monthly OCA newsletter to receive updates here:
For class action settlements and more ways to earn cash keep scrolling below!
Hair Straightener Cancer Investigation
Airlines Class Action